PUQE-M: Nutritional Markers in Normal and Hyperemesis Pregnancies

Sponsor
Haukeland University Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT02619188
Collaborator
University of Bergen (Other)
60
1
34
1.8

Study Details

Study Description

Brief Summary

This study evaluate the rate of nausea and nutritional status in patients with hyperemesis gravidarum (severe nausea and vomiting in pregnancy) and healthy pregnant women using a questionnaire (PUQE-score), self-reported food/drink intake form and blood test. The Investigators aim for developing normal range of prealbumin measurements (reference values) during first trimester of pregnancy.

Condition or Disease Intervention/Treatment Phase
  • Other: PUQE-form inclusion
  • Other: Nutritional form inclusion
  • Other: Blood sampling inclusion
  • Other: Intervention at discharge

Detailed Description

Women affected with hyperemesis gravidarum are at severe nutritional risk. Reference values for biochemical parameters evaluating nutritional status during early pregnancy needs to be determined.

The investigators will compare clinical nutritional parameters (weight gain/weight loss) with rate of nausea (PUQE-questionnaire), self-reported nutritional intake form and biochemical measurements (prealbumin) in women admitted to hospital with hyperemesis gravidarum and healthy pregnant women.

For hyperemesis patients measurements will be repeated at discharge.

Study Design

Study Type:
Observational
Anticipated Enrollment :
60 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Pregnancy Unique Questionnaire of Emesis (PUQE) Methode Evaluation; Relation Between Rate of Nausea/Vomiting in Pregnancy (PUQE-score), Self-reported Nutritional Intake and Biochemical Nutritional Markers
Study Start Date :
Sep 1, 2015
Anticipated Primary Completion Date :
May 1, 2017
Anticipated Study Completion Date :
Jul 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Hyperemesis gravidarum

Hyperemesis gravidarum patients admitted to hospital PUQE-form inclusion (PUQE-score), Nutritional form inclusion, Blood sampling inclusion (Prealbumin analysis), Intervention at discharge : PUQE-form, Nutritional form and Blood sampling

Other: PUQE-form inclusion
PUQE-form encompassing last 24 hours completion
Other Names:
  • Pregnancy Unique Questionnare of Emesis
  • Other: Nutritional form inclusion
    Food-list form encompassing last 24 hours completion

    Other: Blood sampling inclusion
    Measurement of biochemical nutrition marker(s); Prealbumin

    Other: Intervention at discharge
    PUQE-form, nutritional form and Blood sampling

    Control: Healthy pregnant women

    Outpatients NOT subjected to severe nausea and emesis (PUQE-score <13). PUQE-form inclusion (PUQE-score), Nutritional form inclusion, Blood sampling inclusion (Prealbumin analysis).

    Other: PUQE-form inclusion
    PUQE-form encompassing last 24 hours completion
    Other Names:
  • Pregnancy Unique Questionnare of Emesis
  • Other: Nutritional form inclusion
    Food-list form encompassing last 24 hours completion

    Other: Blood sampling inclusion
    Measurement of biochemical nutrition marker(s); Prealbumin

    Outcome Measures

    Primary Outcome Measures

    1. Prealbumin in normal pregnancy [Within 24h at inclusion]

      Serum Prealbumin measured during first trimester of pregnancy

    Secondary Outcome Measures

    1. Prealbumin related to nutritional parameters [Within 24h at inclusion]

      Prealbumin level correlated to PUQE-score and weight change in normal and hyperemesis pregnancies

    2. Change in Prealbumin [Patients will be followed until discharge from hospital, a mean of 5 days, and blood sampling repeated at discharge]

      Change in Serum Prealbumin during hospital treatment of hyperemesis gravidarum

    3. Prealbumin in Hyperemesis gravidarum [Within 2h from admission to hospital]

      Serum Prealbumin measured when admission to hospital

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 50 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Pregnant women < 16 weeks of gestation

    • Admitted to hospital for hyperemesis gravidarum (HG group) with nausea and vomiting in pregnancy with at least two of following criteria; weight loss, dehydration, fluid-/electrolyte disturbances, ketonuria

    Exclusion Criteria:
    • Non-viable pregnancy diagnosed at time of inclusion

    • Unable to understand Norwegian

    • PUQE-score >= 13 (control group)

    • Nausea an vomiting in pregnancy caused by other conditions than Hyperemesis gravidarum

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Dpt. of Obstetrics and Gynaecology, Haukeland University Hospital Bergen Hordaland Norway 5021

    Sponsors and Collaborators

    • Haukeland University Hospital
    • University of Bergen

    Investigators

    • Principal Investigator: Jone Trovik, MD, PhD, Senior consultant

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Haukeland University Hospital
    ClinicalTrials.gov Identifier:
    NCT02619188
    Other Study ID Numbers:
    • 2015/894
    First Posted:
    Dec 2, 2015
    Last Update Posted:
    Oct 5, 2016
    Last Verified:
    Oct 1, 2016
    Keywords provided by Haukeland University Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 5, 2016